These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Stereospecific effects of opiate antagonists on superficial and deep nociception and on motor activity suggest involvement of endorphins on different opioid receptors. Ramabadran K; Jacob JJ Life Sci; 1979 May; 24(21):1959-69. PubMed ID: 222987 [No Abstract] [Full Text] [Related]
6. Electroacupuncture analgesia is mediated by stereospecific opiate receptors and is reversed by antagonists of type I receptors. Cheng RS; Pomeranz BH Life Sci; 1980 Feb; 26(8):631-8. PubMed ID: 6247596 [No Abstract] [Full Text] [Related]
7. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus. Pilcher CW; Browne JL NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994 [TBL] [Abstract][Full Text] [Related]
8. Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia. Parratt JR; Sitsapesan R Br J Pharmacol; 1986 Apr; 87(4):621-2. PubMed ID: 3011165 [TBL] [Abstract][Full Text] [Related]
9. Aversive properties of narcotic antagonists in rats. Stolerman IP; Pilcher CW; D'Mello G Neuropharmacology; 1978 Jun; 17(6):427. PubMed ID: 673159 [No Abstract] [Full Text] [Related]
10. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock. Curtis MT; Lefer AM Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706 [TBL] [Abstract][Full Text] [Related]
11. Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum. Waterfield AA; Kosterlitz HW Life Sci; 1975 Jun; 16(12):1787-92. PubMed ID: 1152603 [No Abstract] [Full Text] [Related]
14. Comparison in the mouse of the effect of the opiate delta receptor antagonist ICI 154129 and naloxone in tests of extinction, passive avoidance and food intake. Benton D; Dalrymple-Alford JC; McAllister KH; Brain PF; Brain S Psychopharmacology (Berl); 1984; 82(1-2):41-5. PubMed ID: 6320249 [TBL] [Abstract][Full Text] [Related]
16. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats. Hartig U; Opitz K Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194 [TBL] [Abstract][Full Text] [Related]
17. Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats. Bhargava HN; Kremer EK; Gibbons MO; Philips BJ; Driver JW; Chou M Eur J Pharmacol; 1989 Dec; 173(2-3):159-64. PubMed ID: 2560431 [TBL] [Abstract][Full Text] [Related]
18. Tripeptides acting on opioid receptors in rat colon. Moritoki H; Takei M; Kotani M; Kiso Y; Ishida Y; Endoh K Eur J Pharmacol; 1984 Apr; 100(1):29-39. PubMed ID: 6202530 [TBL] [Abstract][Full Text] [Related]
19. Further study of kappa opioids on increased urination. Leander JD J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward. Kirkham TC; Cooper SJ Physiol Behav; 1988; 43(6):845-7. PubMed ID: 2853375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]